nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP3A4—type 2 diabetes mellitus	0.281	1	CbGaD
Oxymorphone—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0423	0.101	CbGbCtD
Oxymorphone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0417	0.0998	CbGbCtD
Oxymorphone—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.039	0.0934	CbGbCtD
Oxymorphone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0372	0.089	CbGbCtD
Oxymorphone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.034	0.0814	CbGbCtD
Oxymorphone—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.032	0.0767	CbGbCtD
Oxymorphone—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0307	0.0735	CbGbCtD
Oxymorphone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0297	0.0711	CbGbCtD
Oxymorphone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0269	0.0643	CbGbCtD
Oxymorphone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0204	0.0488	CbGbCtD
Oxymorphone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0195	0.0467	CbGbCtD
Oxymorphone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0195	0.0467	CbGbCtD
Oxymorphone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0185	0.0442	CbGbCtD
Oxymorphone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0138	0.0329	CbGbCtD
Oxymorphone—CYP3A4—Losartan—type 2 diabetes mellitus	0.0126	0.0301	CbGbCtD
Oxymorphone—Dihydrocodeine—CYP3A4—type 2 diabetes mellitus	0.00038	0.155	CrCbGaD
Oxymorphone—Buprenorphine—CYP1A2—type 2 diabetes mellitus	0.00037	0.151	CrCbGaD
Oxymorphone—Hydrocodone—CYP3A4—type 2 diabetes mellitus	0.000292	0.119	CrCbGaD
Oxymorphone—Oxycodone—CYP3A4—type 2 diabetes mellitus	0.000266	0.108	CrCbGaD
Oxymorphone—Buprenorphine—CYP3A4—type 2 diabetes mellitus	0.000245	0.0998	CrCbGaD
Oxymorphone—Naloxone—CYP3A4—type 2 diabetes mellitus	0.000243	0.0991	CrCbGaD
Oxymorphone—Hydromorphone—CYP3A4—type 2 diabetes mellitus	0.000242	0.0983	CrCbGaD
Oxymorphone—Naloxone—ALB—type 2 diabetes mellitus	0.000212	0.0864	CrCbGaD
Oxymorphone—Morphine—CYP3A4—type 2 diabetes mellitus	0.000205	0.0836	CrCbGaD
Oxymorphone—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000203	0.000889	CcSEcCtD
Oxymorphone—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000203	0.000889	CcSEcCtD
Oxymorphone—Agitation—Irbesartan—type 2 diabetes mellitus	0.000203	0.000888	CcSEcCtD
Oxymorphone—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000203	0.000888	CcSEcCtD
Oxymorphone—Hypertension—Metformin—type 2 diabetes mellitus	0.000202	0.000884	CcSEcCtD
Oxymorphone—Urticaria—Glyburide—type 2 diabetes mellitus	0.000202	0.000884	CcSEcCtD
Oxymorphone—Nervousness—Losartan—type 2 diabetes mellitus	0.000201	0.000883	CcSEcCtD
Oxymorphone—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000201	0.000881	CcSEcCtD
Oxymorphone—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000201	0.000879	CcSEcCtD
Oxymorphone—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000201	0.000879	CcSEcCtD
Oxymorphone—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.0002	0.000877	CcSEcCtD
Oxymorphone—Anorexia—Valsartan—type 2 diabetes mellitus	0.000199	0.000875	CcSEcCtD
Oxymorphone—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000199	0.000873	CcSEcCtD
Oxymorphone—Chest pain—Metformin—type 2 diabetes mellitus	0.000199	0.000872	CcSEcCtD
Oxymorphone—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000198	0.000868	CcSEcCtD
Oxymorphone—Headache—Pioglitazone—type 2 diabetes mellitus	0.000198	0.000868	CcSEcCtD
Oxymorphone—Syncope—Irbesartan—type 2 diabetes mellitus	0.000198	0.000867	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000197	0.000866	CcSEcCtD
Oxymorphone—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000197	0.000863	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000197	0.000862	CcSEcCtD
Oxymorphone—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000196	0.000861	CcSEcCtD
Oxymorphone—Nausea—Glipizide—type 2 diabetes mellitus	0.000196	0.000859	CcSEcCtD
Oxymorphone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000196	0.000858	CcSEcCtD
Oxymorphone—Hypotension—Valsartan—type 2 diabetes mellitus	0.000196	0.000858	CcSEcCtD
Oxymorphone—Vision blurred—Losartan—type 2 diabetes mellitus	0.000195	0.000857	CcSEcCtD
Oxymorphone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000195	0.000855	CcSEcCtD
Oxymorphone—Pain—Gliclazide—type 2 diabetes mellitus	0.000195	0.000854	CcSEcCtD
Oxymorphone—Constipation—Gliclazide—type 2 diabetes mellitus	0.000195	0.000854	CcSEcCtD
Oxymorphone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000194	0.00085	CcSEcCtD
Oxymorphone—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000194	0.000849	CcSEcCtD
Oxymorphone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000193	0.000847	CcSEcCtD
Oxymorphone—Headache—Glimepiride—type 2 diabetes mellitus	0.000193	0.000845	CcSEcCtD
Oxymorphone—Headache—Sitagliptin—type 2 diabetes mellitus	0.000192	0.000842	CcSEcCtD
Oxymorphone—Agitation—Losartan—type 2 diabetes mellitus	0.000191	0.000836	CcSEcCtD
Oxymorphone—Oedema—Metformin—type 2 diabetes mellitus	0.000191	0.000836	CcSEcCtD
Oxymorphone—Hypertension—Irbesartan—type 2 diabetes mellitus	0.00019	0.000834	CcSEcCtD
Oxymorphone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00019	0.000833	CcSEcCtD
Oxymorphone—Flushing—Ramipril—type 2 diabetes mellitus	0.00019	0.000831	CcSEcCtD
Oxymorphone—Insomnia—Valsartan—type 2 diabetes mellitus	0.000189	0.00083	CcSEcCtD
Oxymorphone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000188	0.000823	CcSEcCtD
Oxymorphone—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000188	0.000823	CcSEcCtD
Oxymorphone—Shock—Metformin—type 2 diabetes mellitus	0.000188	0.000822	CcSEcCtD
Oxymorphone—Insomnia—Orlistat—type 2 diabetes mellitus	0.000187	0.00082	CcSEcCtD
Oxymorphone—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000187	0.00082	CcSEcCtD
Oxymorphone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000187	0.00082	CcSEcCtD
Oxymorphone—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000187	0.00082	CcSEcCtD
Oxymorphone—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000187	0.000818	CcSEcCtD
Oxymorphone—Vertigo—Losartan—type 2 diabetes mellitus	0.000186	0.000817	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000186	0.000817	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000186	0.000817	CcSEcCtD
Oxymorphone—Somnolence—Valsartan—type 2 diabetes mellitus	0.000186	0.000816	CcSEcCtD
Oxymorphone—Syncope—Losartan—type 2 diabetes mellitus	0.000186	0.000816	CcSEcCtD
Oxymorphone—Skin disorder—Metformin—type 2 diabetes mellitus	0.000185	0.000812	CcSEcCtD
Oxymorphone—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000185	0.000809	CcSEcCtD
Oxymorphone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000184	0.000808	CcSEcCtD
Oxymorphone—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000184	0.000808	CcSEcCtD
Oxymorphone—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000184	0.000807	CcSEcCtD
Oxymorphone—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000184	0.000805	CcSEcCtD
Oxymorphone—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000183	0.000805	CcSEcCtD
Oxymorphone—Palpitations—Losartan—type 2 diabetes mellitus	0.000183	0.000804	CcSEcCtD
Oxymorphone—Nausea—Glimepiride—type 2 diabetes mellitus	0.000183	0.000801	CcSEcCtD
Oxymorphone—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000182	0.000799	CcSEcCtD
Oxymorphone—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000182	0.000799	CcSEcCtD
Oxymorphone—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000182	0.000798	CcSEcCtD
Oxymorphone—Asthenia—Glyburide—type 2 diabetes mellitus	0.000182	0.000798	CcSEcCtD
Oxymorphone—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000182	0.000798	CcSEcCtD
Oxymorphone—Anorexia—Metformin—type 2 diabetes mellitus	0.000182	0.000797	CcSEcCtD
Oxymorphone—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000181	0.000794	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000181	0.000792	CcSEcCtD
Oxymorphone—Fatigue—Valsartan—type 2 diabetes mellitus	0.00018	0.000791	CcSEcCtD
Oxymorphone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00018	0.00079	CcSEcCtD
Oxymorphone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00018	0.00079	CcSEcCtD
Oxymorphone—Oedema—Irbesartan—type 2 diabetes mellitus	0.00018	0.000789	CcSEcCtD
Oxymorphone—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00018	0.000788	CcSEcCtD
Oxymorphone—Pruritus—Glyburide—type 2 diabetes mellitus	0.000179	0.000787	CcSEcCtD
Oxymorphone—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000179	0.000785	CcSEcCtD
Oxymorphone—Constipation—Valsartan—type 2 diabetes mellitus	0.000179	0.000785	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000179	0.000783	CcSEcCtD
Oxymorphone—Fatigue—Orlistat—type 2 diabetes mellitus	0.000178	0.000782	CcSEcCtD
Oxymorphone—Hypotension—Metformin—type 2 diabetes mellitus	0.000178	0.000781	CcSEcCtD
Oxymorphone—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000178	0.00078	CcSEcCtD
Oxymorphone—Shock—Irbesartan—type 2 diabetes mellitus	0.000177	0.000776	CcSEcCtD
Oxymorphone—Pain—Orlistat—type 2 diabetes mellitus	0.000177	0.000776	CcSEcCtD
Oxymorphone—Chest pain—Losartan—type 2 diabetes mellitus	0.000177	0.000774	CcSEcCtD
Oxymorphone—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000176	0.000774	CcSEcCtD
Oxymorphone—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000176	0.000773	CcSEcCtD
Oxymorphone—Anxiety—Losartan—type 2 diabetes mellitus	0.000176	0.000772	CcSEcCtD
Oxymorphone—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000176	0.00077	CcSEcCtD
Oxymorphone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000175	0.000767	CcSEcCtD
Oxymorphone—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000175	0.000766	CcSEcCtD
Oxymorphone—Tension—Ramipril—type 2 diabetes mellitus	0.000175	0.000765	CcSEcCtD
Oxymorphone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000174	0.000762	CcSEcCtD
Oxymorphone—Headache—Bromocriptine—type 2 diabetes mellitus	0.000174	0.000762	CcSEcCtD
Oxymorphone—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000174	0.000761	CcSEcCtD
Oxymorphone—Nervousness—Ramipril—type 2 diabetes mellitus	0.000173	0.000757	CcSEcCtD
Oxymorphone—Dry mouth—Losartan—type 2 diabetes mellitus	0.000173	0.000757	CcSEcCtD
Oxymorphone—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000171	0.000752	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000171	0.00075	CcSEcCtD
Oxymorphone—Confusional state—Losartan—type 2 diabetes mellitus	0.000171	0.000748	CcSEcCtD
Oxymorphone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00017	0.000747	CcSEcCtD
Oxymorphone—Dyspnoea—Metformin—type 2 diabetes mellitus	0.00017	0.000745	CcSEcCtD
Oxymorphone—Somnolence—Metformin—type 2 diabetes mellitus	0.000169	0.000743	CcSEcCtD
Oxymorphone—Oedema—Losartan—type 2 diabetes mellitus	0.000169	0.000742	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000169	0.000742	CcSEcCtD
Oxymorphone—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000168	0.000737	CcSEcCtD
Oxymorphone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000168	0.000736	CcSEcCtD
Oxymorphone—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000168	0.000736	CcSEcCtD
Oxymorphone—Shock—Losartan—type 2 diabetes mellitus	0.000167	0.00073	CcSEcCtD
Oxymorphone—Urticaria—Valsartan—type 2 diabetes mellitus	0.000166	0.000729	CcSEcCtD
Oxymorphone—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000166	0.000728	CcSEcCtD
Oxymorphone—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000166	0.000727	CcSEcCtD
Oxymorphone—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000165	0.000726	CcSEcCtD
Oxymorphone—Tachycardia—Losartan—type 2 diabetes mellitus	0.000165	0.000724	CcSEcCtD
Oxymorphone—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000165	0.000723	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000165	0.000722	CcSEcCtD
Oxymorphone—Fatigue—Metformin—type 2 diabetes mellitus	0.000164	0.000721	CcSEcCtD
Oxymorphone—Urticaria—Orlistat—type 2 diabetes mellitus	0.000164	0.00072	CcSEcCtD
Oxymorphone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000164	0.000718	CcSEcCtD
Oxymorphone—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000163	0.000717	CcSEcCtD
Oxymorphone—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000163	0.000717	CcSEcCtD
Oxymorphone—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000163	0.000717	CcSEcCtD
Oxymorphone—Agitation—Ramipril—type 2 diabetes mellitus	0.000163	0.000717	CcSEcCtD
Oxymorphone—Constipation—Metformin—type 2 diabetes mellitus	0.000163	0.000715	CcSEcCtD
Oxymorphone—Anorexia—Losartan—type 2 diabetes mellitus	0.000161	0.000708	CcSEcCtD
Oxymorphone—Vomiting—Glyburide—type 2 diabetes mellitus	0.000161	0.000707	CcSEcCtD
Oxymorphone—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000161	0.000707	CcSEcCtD
Oxymorphone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.00016	0.000703	CcSEcCtD
Oxymorphone—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00016	0.000701	CcSEcCtD
Oxymorphone—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00016	0.000701	CcSEcCtD
Oxymorphone—Vertigo—Ramipril—type 2 diabetes mellitus	0.00016	0.000701	CcSEcCtD
Oxymorphone—Syncope—Ramipril—type 2 diabetes mellitus	0.000159	0.000699	CcSEcCtD
Oxymorphone—Headache—Glyburide—type 2 diabetes mellitus	0.000159	0.000697	CcSEcCtD
Oxymorphone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000158	0.000694	CcSEcCtD
Oxymorphone—Hypotension—Losartan—type 2 diabetes mellitus	0.000158	0.000694	CcSEcCtD
Oxymorphone—Palpitations—Ramipril—type 2 diabetes mellitus	0.000157	0.000689	CcSEcCtD
Oxymorphone—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000157	0.000689	CcSEcCtD
Oxymorphone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000156	0.000686	CcSEcCtD
Oxymorphone—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000156	0.000685	CcSEcCtD
Oxymorphone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000156	0.000683	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000156	0.000683	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000155	0.000681	CcSEcCtD
Oxymorphone—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000155	0.00068	CcSEcCtD
Oxymorphone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000154	0.000676	CcSEcCtD
Oxymorphone—Convulsion—Ramipril—type 2 diabetes mellitus	0.000154	0.000676	CcSEcCtD
Oxymorphone—Pain—Irbesartan—type 2 diabetes mellitus	0.000154	0.000674	CcSEcCtD
Oxymorphone—Constipation—Irbesartan—type 2 diabetes mellitus	0.000154	0.000674	CcSEcCtD
Oxymorphone—Insomnia—Losartan—type 2 diabetes mellitus	0.000153	0.000671	CcSEcCtD
Oxymorphone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000152	0.000668	CcSEcCtD
Oxymorphone—Urticaria—Metformin—type 2 diabetes mellitus	0.000151	0.000664	CcSEcCtD
Oxymorphone—Chest pain—Ramipril—type 2 diabetes mellitus	0.000151	0.000664	CcSEcCtD
Oxymorphone—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000151	0.000662	CcSEcCtD
Oxymorphone—Anxiety—Ramipril—type 2 diabetes mellitus	0.000151	0.000662	CcSEcCtD
Oxymorphone—Nausea—Glyburide—type 2 diabetes mellitus	0.000151	0.000661	CcSEcCtD
Oxymorphone—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000151	0.000661	CcSEcCtD
Oxymorphone—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000151	0.000661	CcSEcCtD
Oxymorphone—Somnolence—Losartan—type 2 diabetes mellitus	0.00015	0.00066	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.00015	0.000659	CcSEcCtD
Oxymorphone—Asthenia—Valsartan—type 2 diabetes mellitus	0.00015	0.000658	CcSEcCtD
Oxymorphone—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000149	0.000653	CcSEcCtD
Oxymorphone—Asthenia—Orlistat—type 2 diabetes mellitus	0.000148	0.000651	CcSEcCtD
Oxymorphone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000148	0.00065	CcSEcCtD
Oxymorphone—Pruritus—Valsartan—type 2 diabetes mellitus	0.000148	0.000649	CcSEcCtD
Oxymorphone—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000148	0.000649	CcSEcCtD
Oxymorphone—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000147	0.000645	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000147	0.000645	CcSEcCtD
Oxymorphone—Confusional state—Ramipril—type 2 diabetes mellitus	0.000146	0.000642	CcSEcCtD
Oxymorphone—Pruritus—Orlistat—type 2 diabetes mellitus	0.000146	0.000642	CcSEcCtD
Oxymorphone—Fatigue—Losartan—type 2 diabetes mellitus	0.000146	0.00064	CcSEcCtD
Oxymorphone—Oedema—Ramipril—type 2 diabetes mellitus	0.000145	0.000636	CcSEcCtD
Oxymorphone—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000145	0.000635	CcSEcCtD
Oxymorphone—Constipation—Losartan—type 2 diabetes mellitus	0.000145	0.000635	CcSEcCtD
Oxymorphone—Pain—Losartan—type 2 diabetes mellitus	0.000145	0.000635	CcSEcCtD
Oxymorphone—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000143	0.000629	CcSEcCtD
Oxymorphone—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000143	0.000628	CcSEcCtD
Oxymorphone—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000143	0.000627	CcSEcCtD
Oxymorphone—Shock—Ramipril—type 2 diabetes mellitus	0.000143	0.000626	CcSEcCtD
Oxymorphone—Headache—Gliclazide—type 2 diabetes mellitus	0.000143	0.000626	CcSEcCtD
Oxymorphone—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000142	0.000624	CcSEcCtD
Oxymorphone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000142	0.000623	CcSEcCtD
Oxymorphone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000142	0.000623	CcSEcCtD
Oxymorphone—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000142	0.000621	CcSEcCtD
Oxymorphone—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000141	0.00062	CcSEcCtD
Oxymorphone—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000141	0.000618	CcSEcCtD
Oxymorphone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.00014	0.000615	CcSEcCtD
Oxymorphone—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000139	0.000612	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000138	0.000607	CcSEcCtD
Oxymorphone—Dizziness—Valsartan—type 2 diabetes mellitus	0.000138	0.000607	CcSEcCtD
Oxymorphone—Anorexia—Ramipril—type 2 diabetes mellitus	0.000138	0.000607	CcSEcCtD
Oxymorphone—Dizziness—Orlistat—type 2 diabetes mellitus	0.000137	0.0006	CcSEcCtD
Oxymorphone—Asthenia—Metformin—type 2 diabetes mellitus	0.000137	0.0006	CcSEcCtD
Oxymorphone—Hypotension—Ramipril—type 2 diabetes mellitus	0.000136	0.000595	CcSEcCtD
Oxymorphone—Nausea—Gliclazide—type 2 diabetes mellitus	0.000135	0.000593	CcSEcCtD
Oxymorphone—Pruritus—Metformin—type 2 diabetes mellitus	0.000135	0.000591	CcSEcCtD
Oxymorphone—Urticaria—Losartan—type 2 diabetes mellitus	0.000134	0.00059	CcSEcCtD
Oxymorphone—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000134	0.000587	CcSEcCtD
Oxymorphone—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000134	0.000587	CcSEcCtD
Oxymorphone—Vomiting—Valsartan—type 2 diabetes mellitus	0.000133	0.000584	CcSEcCtD
Oxymorphone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000133	0.000581	CcSEcCtD
Oxymorphone—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000132	0.000578	CcSEcCtD
Oxymorphone—Vomiting—Orlistat—type 2 diabetes mellitus	0.000131	0.000577	CcSEcCtD
Oxymorphone—Insomnia—Ramipril—type 2 diabetes mellitus	0.000131	0.000576	CcSEcCtD
Oxymorphone—Headache—Valsartan—type 2 diabetes mellitus	0.000131	0.000575	CcSEcCtD
Oxymorphone—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00013	0.000572	CcSEcCtD
Oxymorphone—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00013	0.000571	CcSEcCtD
Oxymorphone—Headache—Orlistat—type 2 diabetes mellitus	0.00013	0.000568	CcSEcCtD
Oxymorphone—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000129	0.000567	CcSEcCtD
Oxymorphone—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000129	0.000566	CcSEcCtD
Oxymorphone—Somnolence—Ramipril—type 2 diabetes mellitus	0.000129	0.000566	CcSEcCtD
Oxymorphone—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000128	0.00056	CcSEcCtD
Oxymorphone—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000127	0.000558	CcSEcCtD
Oxymorphone—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000126	0.000553	CcSEcCtD
Oxymorphone—Dizziness—Metformin—type 2 diabetes mellitus	0.000126	0.000553	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000125	0.000549	CcSEcCtD
Oxymorphone—Fatigue—Ramipril—type 2 diabetes mellitus	0.000125	0.000549	CcSEcCtD
Oxymorphone—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000125	0.000547	CcSEcCtD
Oxymorphone—Nausea—Valsartan—type 2 diabetes mellitus	0.000124	0.000545	CcSEcCtD
Oxymorphone—Constipation—Ramipril—type 2 diabetes mellitus	0.000124	0.000544	CcSEcCtD
Oxymorphone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000123	0.00054	CcSEcCtD
Oxymorphone—Nausea—Orlistat—type 2 diabetes mellitus	0.000123	0.000539	CcSEcCtD
Oxymorphone—Asthenia—Losartan—type 2 diabetes mellitus	0.000121	0.000533	CcSEcCtD
Oxymorphone—Vomiting—Metformin—type 2 diabetes mellitus	0.000121	0.000531	CcSEcCtD
Oxymorphone—Dermatitis—Metformin—type 2 diabetes mellitus	0.00012	0.000526	CcSEcCtD
Oxymorphone—Pruritus—Losartan—type 2 diabetes mellitus	0.00012	0.000525	CcSEcCtD
Oxymorphone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00012	0.000524	CcSEcCtD
Oxymorphone—Headache—Metformin—type 2 diabetes mellitus	0.000119	0.000524	CcSEcCtD
Oxymorphone—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000119	0.000522	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000119	0.00052	CcSEcCtD
Oxymorphone—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000116	0.000508	CcSEcCtD
Oxymorphone—Urticaria—Ramipril—type 2 diabetes mellitus	0.000115	0.000506	CcSEcCtD
Oxymorphone—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000115	0.000503	CcSEcCtD
Oxymorphone—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000115	0.000503	CcSEcCtD
Oxymorphone—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000114	0.000501	CcSEcCtD
Oxymorphone—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000113	0.000497	CcSEcCtD
Oxymorphone—Nausea—Metformin—type 2 diabetes mellitus	0.000113	0.000496	CcSEcCtD
Oxymorphone—Headache—Irbesartan—type 2 diabetes mellitus	0.000113	0.000494	CcSEcCtD
Oxymorphone—Dizziness—Losartan—type 2 diabetes mellitus	0.000112	0.000491	CcSEcCtD
Oxymorphone—Vomiting—Losartan—type 2 diabetes mellitus	0.000108	0.000472	CcSEcCtD
Oxymorphone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000107	0.000469	CcSEcCtD
Oxymorphone—Nausea—Irbesartan—type 2 diabetes mellitus	0.000107	0.000468	CcSEcCtD
Oxymorphone—Dermatitis—Losartan—type 2 diabetes mellitus	0.000107	0.000468	CcSEcCtD
Oxymorphone—Headache—Losartan—type 2 diabetes mellitus	0.000106	0.000465	CcSEcCtD
Oxymorphone—Asthenia—Ramipril—type 2 diabetes mellitus	0.000104	0.000457	CcSEcCtD
Oxymorphone—Pruritus—Ramipril—type 2 diabetes mellitus	0.000103	0.00045	CcSEcCtD
Oxymorphone—Nausea—Losartan—type 2 diabetes mellitus	0.000101	0.000441	CcSEcCtD
Oxymorphone—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.93e-05	0.000435	CcSEcCtD
Oxymorphone—Dizziness—Ramipril—type 2 diabetes mellitus	9.6e-05	0.000421	CcSEcCtD
Oxymorphone—Vomiting—Ramipril—type 2 diabetes mellitus	9.23e-05	0.000405	CcSEcCtD
Oxymorphone—Dermatitis—Ramipril—type 2 diabetes mellitus	9.14e-05	0.000401	CcSEcCtD
Oxymorphone—Headache—Ramipril—type 2 diabetes mellitus	9.09e-05	0.000399	CcSEcCtD
Oxymorphone—Nausea—Ramipril—type 2 diabetes mellitus	8.62e-05	0.000378	CcSEcCtD
Oxymorphone—OPRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.69e-05	0.000238	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.68e-05	0.000238	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.67e-05	0.000236	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.67e-05	0.000236	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.67e-05	0.000236	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.66e-05	0.000235	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.64e-05	0.000232	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—C3—type 2 diabetes mellitus	1.64e-05	0.000231	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	1.62e-05	0.000229	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.61e-05	0.000227	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.59e-05	0.000225	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.58e-05	0.000223	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.58e-05	0.000222	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.56e-05	0.00022	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.56e-05	0.00022	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.56e-05	0.00022	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.55e-05	0.000219	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.54e-05	0.000218	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.54e-05	0.000218	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.53e-05	0.000216	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.52e-05	0.000215	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.52e-05	0.000215	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	1.52e-05	0.000215	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.51e-05	0.000213	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.49e-05	0.000211	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.49e-05	0.000211	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.49e-05	0.00021	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.49e-05	0.00021	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.49e-05	0.00021	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.49e-05	0.00021	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.49e-05	0.00021	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.48e-05	0.000209	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.47e-05	0.000207	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	1.47e-05	0.000207	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	1.47e-05	0.000207	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.47e-05	0.000207	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.47e-05	0.000207	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.46e-05	0.000206	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.46e-05	0.000206	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.45e-05	0.000205	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.45e-05	0.000204	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.44e-05	0.000204	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.44e-05	0.000203	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—C3—type 2 diabetes mellitus	1.43e-05	0.000202	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.43e-05	0.000202	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.41e-05	0.000199	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	1.41e-05	0.000199	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.4e-05	0.000198	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.39e-05	0.000196	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.37e-05	0.000193	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.36e-05	0.000193	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.36e-05	0.000192	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.36e-05	0.000192	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.36e-05	0.000192	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.36e-05	0.000192	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.35e-05	0.00019	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.34e-05	0.000189	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.34e-05	0.000189	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.34e-05	0.000189	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.33e-05	0.000187	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.32e-05	0.000186	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.32e-05	0.000186	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	1.31e-05	0.000185	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—INS—type 2 diabetes mellitus	1.3e-05	0.000184	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.28e-05	0.000181	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.27e-05	0.000179	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.27e-05	0.000179	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.27e-05	0.000179	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.26e-05	0.000178	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.26e-05	0.000178	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.26e-05	0.000178	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.26e-05	0.000178	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.25e-05	0.000177	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.24e-05	0.000175	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.22e-05	0.000172	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.21e-05	0.000171	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.21e-05	0.000171	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—C3—type 2 diabetes mellitus	1.21e-05	0.000171	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	1.2e-05	0.000169	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	1.2e-05	0.000169	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.19e-05	0.000169	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.19e-05	0.000168	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	1.17e-05	0.000166	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.17e-05	0.000165	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.17e-05	0.000165	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	1.17e-05	0.000165	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	1.17e-05	0.000165	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	1.17e-05	0.000165	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	1.16e-05	0.000164	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.16e-05	0.000163	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.15e-05	0.000163	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.15e-05	0.000163	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.15e-05	0.000162	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.14e-05	0.000161	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.14e-05	0.000161	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—INS—type 2 diabetes mellitus	1.14e-05	0.000161	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	1.14e-05	0.000161	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.13e-05	0.00016	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.13e-05	0.000159	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.13e-05	0.000159	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.13e-05	0.000159	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.13e-05	0.000159	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.13e-05	0.000159	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	1.13e-05	0.000159	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.12e-05	0.000158	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.12e-05	0.000157	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.1e-05	0.000156	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.1e-05	0.000156	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.1e-05	0.000155	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.07e-05	0.000152	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.06e-05	0.00015	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.06e-05	0.00015	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.05e-05	0.000148	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	1.05e-05	0.000148	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	1.05e-05	0.000148	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	1.05e-05	0.000148	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	1.03e-05	0.000145	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	1.02e-05	0.000144	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.01e-05	0.000142	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1e-05	0.000141	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1e-05	0.000141	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	9.96e-06	0.000141	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	9.94e-06	0.00014	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.78e-06	0.000138	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.68e-06	0.000137	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	9.64e-06	0.000136	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.62e-06	0.000136	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	9.6e-06	0.000136	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	9.6e-06	0.000136	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	9.6e-06	0.000136	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	9.6e-06	0.000136	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	9.57e-06	0.000135	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.48e-06	0.000134	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	9.46e-06	0.000134	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	9.46e-06	0.000134	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—RELA—type 2 diabetes mellitus	9.42e-06	0.000133	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.32e-06	0.000132	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.32e-06	0.000132	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.28e-06	0.000131	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	9.23e-06	0.00013	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	9.2e-06	0.00013	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.15e-06	0.000129	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	9.07e-06	0.000128	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	9.07e-06	0.000128	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.06e-06	0.000128	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.88e-06	0.000125	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.85e-06	0.000125	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.57e-06	0.000121	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	8.56e-06	0.000121	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.49e-06	0.00012	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.45e-06	0.000119	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.45e-06	0.000119	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	8.44e-06	0.000119	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.44e-06	0.000119	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.22e-06	0.000116	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.03e-06	0.000113	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	7.99e-06	0.000113	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	7.96e-06	0.000112	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.94e-06	0.000112	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	7.82e-06	0.00011	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	7.82e-06	0.00011	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.82e-06	0.00011	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	7.82e-06	0.00011	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.78e-06	0.00011	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	7.78e-06	0.00011	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	7.68e-06	0.000108	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	7.67e-06	0.000108	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	7.63e-06	0.000108	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	7.63e-06	0.000108	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	7.63e-06	0.000108	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	7.58e-06	0.000107	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.54e-06	0.000106	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	7.45e-06	0.000105	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	7.44e-06	0.000105	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SRC—type 2 diabetes mellitus	7.4e-06	0.000104	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.4e-06	0.000104	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	7.36e-06	0.000104	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	7.25e-06	0.000102	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.24e-06	0.000102	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.21e-06	0.000102	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.18e-06	0.000101	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.13e-06	0.000101	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	7.12e-06	0.0001	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	6.97e-06	9.84e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	6.94e-06	9.8e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6.84e-06	9.66e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6.84e-06	9.66e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6.84e-06	9.66e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.78e-06	9.58e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	6.76e-06	9.55e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	6.71e-06	9.48e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.71e-06	9.47e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	6.68e-06	9.43e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	6.65e-06	9.39e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.61e-06	9.34e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.58e-06	9.29e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	6.51e-06	9.19e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.49e-06	9.16e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	6.41e-06	9.05e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	6.29e-06	8.88e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	6.26e-06	8.83e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	6.25e-06	8.83e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	6.19e-06	8.73e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	6.19e-06	8.73e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.09e-06	8.6e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	6.09e-06	8.6e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	5.99e-06	8.45e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	5.97e-06	8.42e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.93e-06	8.37e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.93e-06	8.37e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	5.9e-06	8.33e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.68e-06	8.02e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.59e-06	7.89e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.48e-06	7.74e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.24e-06	7.4e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	5.2e-06	7.34e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.11e-06	7.22e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.11e-06	7.22e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	5.1e-06	7.2e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.09e-06	7.18e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.02e-06	7.09e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.98e-06	7.04e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.87e-06	6.88e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.74e-06	6.69e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	4.67e-06	6.6e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.65e-06	6.57e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.6e-06	6.49e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.56e-06	6.43e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.54e-06	6.41e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.47e-06	6.31e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	4.47e-06	6.31e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.42e-06	6.24e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.37e-06	6.16e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.21e-06	5.95e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.19e-06	5.92e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.11e-06	5.8e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	4.09e-06	5.77e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.98e-06	5.62e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.91e-06	5.53e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.9e-06	5.51e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.89e-06	5.49e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.86e-06	5.44e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.4e-06	4.8e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.33e-06	4.7e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.05e-06	4.31e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.92e-06	4.13e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.92e-06	4.13e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.67e-06	3.77e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	2.05e-06	2.9e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.34e-06	1.9e-05	CbGpPWpGaD
